These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23712717)

  • 1. When do you prescribe antidepressants to depressed children?
    Soutullo C; Figueroa-Quintana A
    Curr Psychiatry Rep; 2013 Jul; 15(7):366. PubMed ID: 23712717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which SSRIs most effectively treat depression in adolescents?
    DeLucia V; Kelsberg G; Safranek S
    J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D; Zhang Z; Zhang X; Li L
    Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
    JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram for the treatment of major depressive disorder in youth.
    Ahn JH; Patkar AA
    Expert Opin Pharmacother; 2011 Oct; 12(14):2235-44. PubMed ID: 21895554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents.
    March JS; Klee BJ; Kremer CM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):91-102. PubMed ID: 16553531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder.
    Li Y; Huang J; He Y; Yang J; Lv Y; Liu H; Liang L; Li H; Zheng Q; Li L
    J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):712-720. PubMed ID: 31368787
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological treatment of children and adolescents with depression.
    Vitiello B; Ordóñez AE
    Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
    Shelton CI
    J Clin Psychiatry; 2004; 65 Suppl 17():29-33. PubMed ID: 15600379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in children and adolescents diagnosed with major depressive disorder: what can we learn from published data?
    Gentile S
    Rev Recent Clin Trials; 2010 Jan; 5(1):63-75. PubMed ID: 20205689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    Ruhé HG; Huyser J; Swinkels JA; Schene AH
    J Clin Psychiatry; 2006 Dec; 67(12):1836-55. PubMed ID: 17194261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.